Literature DB >> 25038063

Aspartame Administration and Insulin Treatment Altered Brain Levels of CYP2E1 and CYP3A2 in Streptozotocin-Induced Diabetic Rats.

Rosario Nosti-Palacios1, Josefina Gómez-Garduño1, Dora Molina-Ortiz1, Raúl Calzada-León2, Víctor Manuel Dorado-González1, Araceli Vences-Mejía3.   

Abstract

This study demonstrates that aspartame consumption and insulin treatment in a juvenile diabetic rat model leads to increase in cytochrome P450 (CYP) 2E1 and CYP3A2 isozymes in brain. Diabetes mellitus was induced in postweaned 21-day-old Wistar male rat by streptozotocin. Animals were randomly assigned to one of the following groups: untreated control, diabetic (D), D-insulin, D-aspartame, or the D-insulin + aspartame-treated group. Brain and liver tissue samples were used to analyze the activity of CYP2E1 and CYP3A2 and protein levels. Our results indicate that combined treatment with insulin and aspartame in juvenile diabetic rats significantly induced CYP2E1 in the cerebrum and cerebellum without modifying it in the liver, while CYP3A2 protein activity increased both in the brain and in the liver. The induction of CYP2E1 in the brain could have important in situ toxicological effects, given that this CYP isoform is capable of bioactivating various toxic substances. Additionally, CYP3A2 induction in the liver and brain could be considered a decisive factor in the variation of drug response and toxicity.
© The Author(s) 2014.

Entities:  

Keywords:  aspartame; brain; cytochrome P450; diabetes; insulin

Mesh:

Substances:

Year:  2014        PMID: 25038063     DOI: 10.1177/1091581814540480

Source DB:  PubMed          Journal:  Int J Toxicol        ISSN: 1091-5818            Impact factor:   2.032


  3 in total

Review 1.  Pathophysiological implications of neurovascular P450 in brain disorders.

Authors:  Chaitali Ghosh; Mohammed Hossain; Jesal Solanki; Aaron Dadas; Nicola Marchi; Damir Janigro
Journal:  Drug Discov Today       Date:  2016-06-14       Impact factor: 7.851

Review 2.  The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain.

Authors:  W A García-Suástegui; L A Ramos-Chávez; M Rubio-Osornio; M Calvillo-Velasco; J A Atzin-Méndez; J Guevara; D Silva-Adaya
Journal:  Oxid Med Cell Longev       Date:  2017-01-10       Impact factor: 6.543

3.  Identification of key genes involved in type 2 diabetic islet dysfunction: a bioinformatics study.

Authors:  Ming Zhong; Yilong Wu; Weijie Ou; Linjing Huang; Liyong Yang
Journal:  Biosci Rep       Date:  2019-05-31       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.